Learn more

CELLZOME AG

Overview
  • Total Patents
    151
About

CELLZOME AG has a total of 151 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are HOWARD FLOREY INST, CASHMAN JOHN R and CHANGZHOU QIANHONG BIO PHARMA CO LTD.

Patent filings per year

Chart showing CELLZOME AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Drewes Gerard 67
#2 Hopf Carsten 52
#3 Ramsden Nigel 31
#4 Ruffner Heinz 29
#5 Kruse Ulrich 29
#6 Reader Valerie 28
#7 Cansfield Andrew 26
#8 Wilson Francis 19
#9 Neubauer Gitte 19
#10 Major Jeremy 16

Latest patents

Publication Filing date Title
WO2013041407A1 Hydroxamic acids as hdac6 inhibitors
WO2013023770A1 Chromatin profiling assay
WO2012175201A1 Methods for the characterization of antibodies
WO2012150042A1 Compounds and methods for the identification of histone demethylase interacting molecules and for the purification of histone demethylase proteins
WO2012123119A1 Methods for the identification and characterization of proteins interacting with histone tails and of compounds interacting with said proteins
WO2012084244A1 A method for the evaluation of compound-target interactions across species
EP2592154A1 Immobilization products and methods for the identification of histone demethylase interacting molecules and for the purification of histone demethylase proteins
EP2596125A1 In vivo method for the evaluation of a compound-target interaction
EP2505659A1 Methods for the identification of dioxygenase interacting molecules and for the purification of dioxygenase proteins
WO2011018241A1 Methods for the identification and characterization of hdac interacting compounds
EP2432782A1 Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins
AU2009248303A1 Methods for the identification of parp interacting molecules and for purification of parp proteins
EP2058307A1 Methods for the identification of JAK kinase interacting molecules and for the purification of JAK kinases
EP1992347A1 Treatment of DDR1 positive cancer using imatinib
WO2007104763A1 Methods for the identification of lrrk2 interacting molecules and for the purification of lrrk2
EP1894931A1 Triazole derivatives as kinase inhibitors
EP1900739A1 Diazolodiazine derivatives as kinase inhibitors
EP1900727A1 Aminopyridine derivatives as kinase inhibitors
WO2007017512A1 Treatment of inflammatory diseases
WO2007017505A2 Treatment of metabolic diseases